CALCAGNO, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 1.650
EU - Europa 436
AS - Asia 340
AF - Africa 8
SA - Sud America 5
OC - Oceania 1
Totale 2.440
Nazione #
US - Stati Uniti d'America 1.632
SG - Singapore 198
IT - Italia 166
SE - Svezia 120
IN - India 72
FI - Finlandia 52
CN - Cina 49
UA - Ucraina 24
DE - Germania 18
CA - Canada 10
GB - Regno Unito 10
RU - Federazione Russa 10
BG - Bulgaria 8
ID - Indonesia 8
RO - Romania 8
IE - Irlanda 7
MX - Messico 7
TG - Togo 6
AR - Argentina 4
FR - Francia 4
QA - Qatar 4
JP - Giappone 3
MK - Macedonia 3
TW - Taiwan 3
KW - Kuwait 2
NL - Olanda 2
AU - Australia 1
BR - Brasile 1
BZ - Belize 1
CZ - Repubblica Ceca 1
ES - Italia 1
GR - Grecia 1
HK - Hong Kong 1
MA - Marocco 1
MU - Mauritius 1
PL - Polonia 1
Totale 2.440
Città #
Fairfield 293
Singapore 157
Ashburn 123
Chandler 121
Woodbridge 112
Cambridge 107
Wilmington 92
Houston 80
Seattle 80
Santa Clara 77
Rome 53
Ann Arbor 47
Princeton 47
San Paolo di Civitate 46
Dearborn 35
Lawrence 35
Helsinki 29
Plano 28
Beijing 25
Millbury 25
Milan 23
Boston 20
San Diego 15
Andover 13
Jakarta 8
Moscow 8
New York 8
Sofia 8
Norwalk 7
Lomé 6
Des Moines 5
Falkenstein 5
Doha 4
Dublin 4
Federal 4
Hefei 4
Mannheim 4
Ottawa 4
Phoenix 4
San Jose 4
Toronto 4
Cupar 3
Drapia 3
Fremont 3
Jacksonville 3
Mexico City 3
Nanjing 3
Acton 2
Amsterdam 2
Bitola 2
Boardman 2
Bologna 2
Bühl 2
Changsha 2
Chengdu 2
Falls Church 2
Guangzhou 2
Guidonia Montecelio 2
Hsinchu 2
Kuwait City 2
Maubourguet 2
Nanchang 2
Pickering 2
San Mateo 2
Tehuacán 2
Tulsa 2
Athens 1
Atlanta 1
Barcelona 1
Bari 1
Belize City 1
Bengaluru 1
Borgoricco 1
Bremen 1
Brisbane 1
Brno 1
Buffalo 1
Chicago 1
Chiusi 1
Città Di Castello 1
Dallas 1
Düsseldorf 1
Frankfurt am Main 1
Fuzhou 1
Gevgelija 1
Gorizia 1
Hayamiya 1
Hyderabad 1
Jinan 1
Kunming 1
Lappeenranta 1
London 1
Los Angeles 1
Lucca 1
Maebashi 1
Mastic Beach 1
Miami 1
Moraga 1
Munich 1
New Bedfont 1
Totale 1.864
Nome #
Comparison of therapy with ticagrelor, prasugrel or high clopidogrel dose in pci patients with high on treatment platelet reactivity and genotype variation. triplete reset trial 121
Enhanced platelet MRP4 expression and correlation with platelet function in patients under chronic aspirin treatment 114
Reply to “Regarding the article of ceccacci et al. (2016; 223: 54–55)” entitled “Role of MIBG scintigraphy in reverse Tako-tsubo cardiomyopathy: confirming a pathophysiologic hypothesis" 90
Effects of ivabradine on residual myocardial ischemia after PCI evaluated by stress echocardiography 89
Effects of statins on plaque rupture assessed by optical coherence tomography in patients presenting with acute coronary syndromes. insights from the optical coherence tomography (OCT)-FORMIDABLE registry 86
Coronary artery bifurcation narrowing treated by axxess stent implantation. the CARINAX registry 83
Rosuvastatin pre-treatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis. The ROMA trial. 82
Effect of adenosine intracoronary bolus on myonecrosis occurrence in elective PCI (RACE trial) 81
Role of MIBG scintigraphy in reverse tako-tsubo cardiomyopathy: confirming a pathophysiologic hypothesis 81
The statin therapy to prevent atrial fibrillation after cardiac surgery. shakespearean dilemma 80
Prasugrel or ticagrelor in st-segment-elevation myocardial infarction patients with diabetes mellitus 80
Beneficial Impact of Prolonged Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation 78
Safety of FFR-guided revascularisation deferral in Anatomically prognostiC disease (FACE. cardiogroup V study). a prospective multicentre study 77
Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity. the INVESTIG8 registry 76
Single-staged compared with multi-staged PCI in multivessel NSTEMI patients. the SMILE trial 71
Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients. the RUDI-FREE study 69
Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial 68
Impact of environmental pollution and weather changes on the incidence of ST-elevation myocardial infarction 66
Culprit plaque characteristics in younger versus older patients with acute coronary syndromes. an optical coherence tomography study from the FORMIDABLE registry 65
ST-elevation myocardial infarction in the COVID-19 era 64
Different orasugrel administration in STEMI patients go faster and no fear to crush 63
Pharmacodynamic effect of switching therapy in patients with high on-treatment platelet reactivity and genotype variation with high clopidogrel dose versus prasugrel the RESET GENE trial 62
The role of ranolazine for the treatment of residual angina beyond the percutaneous coronary revascularization 51
Multiple and Contemporary Coronary Thrombosis inspite of Low Platelet Function Response 50
Acute and long-term outcomes after polytetrafluoroethylene or pericardium covered stenting for grade 3 coronary artery perforations: Insights from G3-CAP registry 50
Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR) 49
The importance of genotype variation beyond different antiplatelet therapy in nonresponder patients. 47
Multimodality imaging in ICD implantation decision making: 123-iodine metaiodobenzylguanidine imaging and cardiac magnetic resonance imaging 46
Safety and effectiveness of the self-aPposing, bAlloon-delivered, siRolimus-eluting stent for the treatment of the coronary artery disease. SPARTA, a multicenter experience 46
Five Years on Dual-Antiplatelet Therapy DES Thrombosis After Clopidogrel Withdrawal 43
A novel algorithm for the computation of the diastolic pressure ratio in the invasive assessment of the functional significance of coronary artery disease 43
Tricuspid leaflet flail after Micra™ leadless pacemaker implantation. A case report 39
Heart failure: TNM-like classification. 37
Do angle and anatomy influence outcomes in bifurcation stenting? 35
Heparins crossover in percutaneous coronary interventions: a real issue with increasing rate of transradial procedures? 30
null 28
Complete systolic obliteration of the left ventricle due to an apical hypertrophic cardiomyopathy in a totally asymptomatic patient. 28
Results of the self-expandable BA9 stent for treatment of large angle coronary bifur-cation. 27
null 26
Do We Really Need Routine CYP2C19 Genotyping? 22
Impact of weather and pollution on the rate of cerebrovascular events in a large metropolitan area 17
null 17
null 17
null 16
Perclose Proglide™ for vascular closure 16
Appraising features and outlook of women and men discharged after an acute coronary syndrome: evidence from the 23,700-patient PRAISE international registry 15
Impact of temporary traffic bans on the risk of acute coronary syndromes in a large metropolitan area 14
Bleeding versus thrombosis: role of short DAPT in complex lesions 14
Renin-Angiotensin Blocking Therapies: A Must-But How?-After Percutaneous Coronary Intervention 14
Left ventricular wall stress is associated with myocardial functional recovery in patients with severe aortic stenosis and systolic dysfunction undergoing transcatheter aortic valve replacement 14
Reduction in emergency access for acute myocardial infarction during the COVID-19 pandemic. A survey from the greater area of Rome 8
Renal arteries denervation. From the treatment of resistant hypertension to the treatment of atrial fibrillation 8
Renal arteries denervation with second generation systems: a remedy for resistant hypertension? 8
null 4
Totale 2.625
Categoria #
all - tutte 8.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.530


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020303 0 0 0 0 0 67 67 52 47 27 21 22
2020/2021282 10 22 8 7 42 8 17 26 46 73 18 5
2021/2022433 24 29 35 17 54 10 12 37 35 33 60 87
2022/2023491 78 126 49 30 39 53 10 20 48 6 28 4
2023/2024236 6 36 12 20 25 23 4 33 5 26 29 17
2024/2025340 19 124 28 25 64 80 0 0 0 0 0 0
Totale 2.625